Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Second patent issues to Zonagen for Vasomax

March 27, 1998

FDA decides future of pimagedine trials

March 26, 1998

New treatments for preterm labor from Merck

March 26, 1998

Vacuolar ATPase inhibitors claimed by SmithKline Beecham for osteoporosis

March 26, 1998

Sumitomo scientists describe new agents for hyperlipidemia

March 26, 1998

Gene therapy for treating growth hormone deficiencies

March 25, 1998

UPMC studies feasibility of gene therapy for osteoporosis

March 25, 1998

Novel treatment for red blood cell disorders available for licensing

March 25, 1998

NIH will license out new technology for studying bone metabolism

March 25, 1998

ST-630 successfully completes phase Ia trial for osteoporosis

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...